LARA MORRIS: Open Payments
NPI 1083721195 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 54 payments from 13 companies in 2025. Trend: 2023 $1,717 · 2024 $1,561 · 2025 $974
Food & beverage: $957Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $255 |
| GlaxoSmithKline, LLC. | 24 | $191 |
| Electromed, Inc. | 4 | $86 |
| Inspire Medical Systems, Inc. | 1 | $81 |
| Grifols USA, LLC | 3 | $72 |
| United Therapeutics Corporation | 3 | $66 |
| Philips North America LLC | 2 | $44 |
| Insmed, Inc. | 2 | $40 |
| JAZZ PHARMACEUTICALS INC. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
Products named: TEZSPIRE, TRELEGY ELLIPTA, SMARTVEST, INSPIRE, Prolastin-C Liquid, NUCALA, FASENRA, Tyvaso.
Industry payments across CO — which companies pay providers there.
